Posts With Tag IoT

Gilead Sciences, Inc. (GILD) files an 8-K report detailing significant events on October 6, 2025. Essential for investors and analysts tracking NASDAQ updates.

Explore Regeneron Pharmaceuticals' 8-K filing from October 6, 2025, detailing significant events, stock info, and investor insights.

Discover critical insights from Dexcom, Inc.'s 8-K filing on September 14, 2025, detailing significant events affecting their common stock.

Activist investor Elliott Management acquires a $4B stake in PepsiCo, pushing for strategic changes to boost stock value amidst industry challenges. Explore the implications for the market.

Discover critical updates from Marriott International (NASDAQ: MAR) in this 8-K report, detailing significant events on August 18, 2025. Essential for investors and stakeholders.

Explore Gilead Sciences, Inc.'s 8-K report detailing significant corporate changes and events affecting investors as of August 7, 2025. Stay informed on GILD's latest developments.

Discover Amgen's impressive Q2 2025 results with $9.179B revenue and $1.432B net income. Learn why it's a buy for investors!

Explore Vertex Pharmaceuticals' impressive Q2 2025 financial performance, featuring $1B net income and rising revenues. A recommended BUY for investors!

Explore Amgen Inc.'s latest 8-K filing detailing common stock and senior notes. Key insights on financing and corporate strategy included.

Explore Marriott's Q2 2025 financial analysis: revenue dips, stable earnings, strategic growth, and market insights.

Discover key insights from Marriott International Inc's 8-K filing dated August 5, 2025. Stay informed on significant corporate developments and stock details.

Discover Gilead Sciences, Inc.'s latest 8-K filing revealing significant shareholder updates as of July 30, 2025. Stay informed on GILD stock and financial transparency.